Eurofins Scientific SE (EPA:ERF)
France · Delayed Price · Currency is EUR 70.44
+0.34 (0.49%)
Aug 14, 2026, 5:35 PM CET
Eurofins Scientific SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,386 | 7,296 | 6,951 | 6,515 | 6,712 | 6,718 | |
Revenue Growth | 3.38% | 4.96% | 6.70% | -2.94% | -0.08% | 23.51% |
Cost of Revenue | 5,677 | 5,655 | 5,399 | 5,151 | 5,199 | 4,816 |
Gross Profit | 1,708 | 1,641 | 1,552 | 1,364 | 1,513 | 1,902 |
Selling, General & Admin | 2.1 | 2.1 | 2.5 | 2.1 | 0.8 | 0.7 |
Operating Expenses | 668 | 677.2 | 654.4 | 646.7 | 604.2 | 543.6 |
Operating Income | 1,040 | 963.7 | 897.8 | 717 | 908.7 | 1,358 |
Interest Expense | -168.8 | -153.9 | -146.5 | -123.4 | -91.6 | -87.4 |
Earnings From Equity Investments | 0.4 | 0.3 | 1 | 0.4 | 0.9 | 2 |
Currency Exchange Gain (Loss) | 3.2 | 24.6 | 4.9 | 11.2 | -32.9 | -17.9 |
Other Non Operating Income (Expenses) | 11.9 | 0.7 | 17.1 | 7.2 | -11.6 | -5.1 |
EBT Excluding Unusual Items | 886.8 | 835.4 | 774.3 | 612.4 | 773.5 | 1,250 |
Merger & Restructuring Charges | -91.7 | -93.6 | -83 | -15.1 | -8.7 | -16.9 |
Gain (Loss) on Sale of Assets | -8.5 | -8.9 | -23.6 | -1.8 | 141.4 | -0.1 |
Other Unusual Items | -59.5 | -78.8 | -113.1 | -172.3 | -126.2 | -176.1 |
Pretax Income | 727.1 | 654.1 | 554.6 | 423.2 | 780 | 1,057 |
Income Tax Expense | 199 | 181.1 | 149.1 | 115.5 | 174.2 | 273.6 |
Earnings From Continuing Operations | 528.1 | 473 | 405.5 | 307.7 | 605.8 | 783 |
Minority Interest in Earnings | 1.5 | 1.8 | 0.9 | 2.5 | 4.4 | -0.4 |
Net Income | 529.6 | 474.8 | 406.4 | 310.2 | 610.2 | 782.6 |
Preferred Dividends & Other Adjustments | 59.7 | 58.7 | 50.1 | 53.7 | 29.3 | 34.1 |
Net Income to Common | 469.9 | 416.1 | 356.3 | 256.5 | 580.9 | 748.5 |
Net Income Growth | 23.27% | 16.78% | 38.91% | -55.84% | -22.39% | 48.13% |
Shares Outstanding (Basic) | 177 | 180 | 191 | 193 | 193 | 192 |
Shares Outstanding (Diluted) | 184 | 187 | 195 | 198 | 199 | 201 |
Shares Change | -3.69% | -4.11% | -1.72% | -0.55% | -0.80% | 2.40% |
EPS (Basic) | 2.66 | 2.31 | 1.87 | 1.33 | 3.02 | 3.91 |
EPS (Diluted) | 2.56 | 2.23 | 1.83 | 1.30 | 2.92 | 3.73 |
EPS Growth | 28.88% | 21.86% | 40.77% | -55.48% | -21.72% | 44.57% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 757.2 | 639 | 865.3 | 539.8 | 560.2 | 1,067 |
Free Cash Flow Per Share | 4.11 | 3.43 | 4.45 | 2.73 | 2.81 | 5.32 |
Dividend Per Share | 0.720 | 0.720 | 0.600 | 0.500 | 1.000 | 1.000 |
Dividend Growth | 20.00% | 20.00% | 20.00% | -50.00% | 0% | 47.06% |
Gross Margin | 23.13% | 22.49% | 22.33% | 20.93% | 22.54% | 28.31% |
Operating Margin | 14.08% | 13.21% | 12.92% | 11.01% | 13.54% | 20.22% |
Profit Margin | 6.36% | 5.70% | 5.13% | 3.94% | 8.65% | 11.14% |
Free Cash Flow Margin | 10.25% | 8.76% | 12.45% | 8.29% | 8.35% | 15.88% |
EBITDA | 1,537 | 1,455 | 1,367 | 1,187 | 1,353 | 1,748 |
EBITDA Margin | 20.81% | 19.95% | 19.66% | 18.22% | 20.15% | 26.02% |
D&A For EBITDA | 497 | 491.5 | 469.1 | 470.1 | 443.8 | 389.9 |
EBIT | 1,040 | 963.7 | 897.8 | 717 | 908.7 | 1,358 |
EBIT Margin | 14.08% | 13.21% | 12.92% | 11.01% | 13.54% | 20.22% |
Effective Tax Rate | 27.37% | 27.69% | 26.88% | 27.29% | 22.33% | 25.89% |